MERCK SHARP DOHME PHARMA TBK PT |
End-of-day quote
Other stock markets
|
||
| - IDR | - |
|
| Managers | Title | Age | Since |
|---|---|---|---|
Daniel
CEO | Chief Executive Officer | 45 | - |
Erwin Agung
DFI | Director of Finance/CFO | - | 18-01-31 |
Yuliana
PRN | Corporate Officer/Principal | 38 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 57 | 11-12-18 | |
Erwin Agung
DFI | Director of Finance/CFO | - | 18-01-31 |
| Chairman | 44 | - |
PT Merck Sharp Dohme Pharma Tbk is an Indonesia-based pharmaceutical company. The Company has two business units: primary care and specialty care. Its primary care products include skin care products, antibiotics, allergy medications and cardiovascular medications. Its specialty care products include hepatology and oncology products as well as opioid dependence medications. It has a manufacturing plant in Pandaan, Indonesia.
Sector
Pharmaceuticals
Calendar
2024-05-29
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +19.75% | 43.67B | |
| +20.67% | 22.51B | |
| +13.82% | 14.6B | |
| +14.29% | 13.74B | |
| +44.19% | 11.91B | |
| -8.37% | 7.04B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +10.21% | 5.42B |
- Stock Market
- Equities
- Stock
